Your Health Insurance Might Soon Be Required to Cover Menopause Care

The Bottom Line

If you or someone you love is dealing with menopause, you know hormone replacement therapy can be a game-changer—but it’s not always covered by insurance. This legislation would legally force most Colorado health insurance plans, including large employers and Medicaid, to cover these treatments without requiring prior authorization. It's a massive shift for women's healthcare access, but it also triggers tiny premium bumps for businesses offering health benefits.

What This Bill Actually Does

Right now, women going through menopause or perimenopause often find that their insurance treats hormone replacement therapy (HRT) as a frustrating gray area. Many policies don't cover it entirely, or they force patients to jump through administrative hoops to get approval. HB26-1122 aims to change that dynamic by legally requiring state-regulated health benefit plans to cover HRT when it's prescribed by a licensed doctor. The fundamental goal is to treat these therapies not as optional or cosmetic treatments, but as standard, necessary medical care for a natural biological process.

The legislation gets highly specific about what counts to prevent insurers from finding loopholes. The bill defines HRT as medical treatments that replace hormones the body is no longer making enough of, explicitly covering FDA-approved methods like:

• Topical creams
• Oral medications
• Hormone pellets
• Vaginal devices

Crucially, the bill prohibits insurance companies from demanding prior authorization or denying coverage that aligns with "generally accepted standards of care." In plain English: once your doctor writes the prescription based on standard medical guidelines, the insurance company cannot make you wait weeks for a corporate review or second-guess your doctor's judgment.

The rollout is staggered to give the insurance market time to adjust without shocking the system. Large employer health plans would need to include this coverage for policies issued or renewed starting January 1, 2027. Individual and small group plans follow a year later on January 1, 2028—with one big caveat. Under federal law, if a state mandates new benefits beyond standard requirements, the state sometimes has to pay the insurers to cover the difference. The bill explicitly pauses the small group mandate if the federal government demands that Colorado defray those costs. Finally, the bill sets a July 1, 2027 deadline for the state Medicaid program to start covering HRT, subject to federal authorization.

What It Means for You

For Colorado women navigating the often-turbulent years of perimenopause and menopause, this bill represents direct financial relief and smoother medical access. If your doctor decides that an estrogen cream or a hormone pellet is the best way to manage severe hot flashes, sleep disruptions, or bone density loss, you wouldn't have to pay entirely out of pocket just because your insurance deems the treatment "non-essential." By stripping away the prior authorization requirement, the legislation ensures you can leave your physician's office and go straight to the pharmacy without the dreaded bureaucratic waiting game that so often delays relief.

It is incredibly important, however, to know whether this mandate actually applies to your specific health insurance policy. This law targets fully insured plans regulated by the Colorado Division of Insurance, as well as the state's Medicaid program (which is a massive win for lower-income residents who often face the steepest barriers to specialized care). But, if you get your health insurance through a large corporation that uses a self-funded plan (where the employer pays employee medical claims directly rather than buying a traditional insurance policy), federal law completely exempts them from state-level mandates like this one. You'll need to check your benefits packet to see which type of plan you have.

The trade-off for expanded mandatory coverage is almost always a slight bump in premium costs. While the state's financial analysts estimate the increase to be incredibly small—around 0.02 percent for state employee plans, for example—any added mandate eventually gets baked into the monthly premiums paid by you or your employer. Still, if you are a family currently spending tens or hundreds of dollars a month out-of-pocket on customized hormone therapies, a microscopic premium trade-off is likely a massive net win for your household budget. It shifts the burden from the individual patient back to the broader insurance pool.

What It Means for Your Business

If you own a business in Colorado and provide health insurance to your team, this bill will slightly shift the landscape of your employee benefits package based on a staggered timeline:

• Large employers: The mandate kicks in for plans issued or renewed on or after January 1, 2027.
• Small businesses: The requirement takes effect a year later, on January 1, 2028.

You don't have to overhaul your plans manually—your insurance broker or carrier will automatically bake this mandatory coverage into your policy upon renewal—but you should absolutely be prepared for it to be a line item in your upcoming renewal discussions.

Adding mandatory benefits always comes with a price tag, even if it is a fractional one. The state's fiscal analysts project that adding hormone replacement therapy will increase total health premiums by roughly 0.02 percent. While that sounds microscopic in isolation, you know better than anyone that it's one more incremental cost layered onto the overall, ever-growing expense of providing employee healthcare. If you run a small business, you will want to factor this tiny bump into your long-term benefit budgeting, especially as you approach the 2028 rollout date for small group plans.

Beyond the strict compliance and cost factors, there is a strategic angle to consider here, especially if your company utilizes a self-funded ERISA plan that is legally exempt from this state law. Menopause care is rapidly becoming a highly valued, talked-about benefit for retaining experienced, mid-career female talent. Untreated severe menopause symptoms frequently lead to lost productivity, increased sick days, and sometimes even early workforce exit. Offering seamless access to HRT without frustrating prior authorization hurdles could be a strong differentiator in a tight labor market, potentially offering a return on investment that outweighs the minimal premium increase.

Follow the Money

The direct cost to Colorado taxpayers for implementing this new rule is practically zero, as no new state appropriations are required. The Division of Insurance will handle the extra administrative workload of reviewing insurance rate and form filings to ensure companies are complying with the new mandate, and they can absorb this task using their existing budget and staff.

The real financial movement happens within the insurance pools themselves. For the state government's own employee health insurance—managed through carriers like Kaiser Permanente and Cigna—covering these therapies is projected to cost up to $70,000 per year starting in FY 2027-28. In the grand scheme of the state's budget, that is a drop in the bucket, amounting to a mere 0.02% premium increase. The current partnership agreement with the Colorado WINS union means the state will likely absorb that premium bump for its own workers through FY 2027-28. Local governments, school districts, and statutory public entities that purchase fully insured plans for their own workforces will likely see a similarly fractional increase in their premium costs, which they will have to navigate during their own local budgeting cycles.

Where This Bill Stands

HB26-1122 is currently Dead. The latest official action came on 02/24/2026: House Committee on Health & Human Services Postpone Indefinitely.

That means the bill is no longer advancing this session. In practice, measures that are postponed indefinitely or otherwise declared lost generally stay dead unless they are reintroduced in a future session.